Skip to main content
. 2016 Oct 25;26(1):52–64. doi: 10.1093/hmg/ddw367

Figure 2.

Figure 2.

Survival of Npc1-/- mice and growth following AAV9 treatment. (A) Kaplan-Meier Curve depicts survival of: Npc1-/- pups (n =6) treated with 2.6 × 1011 GC of AAV9-CamKII-NPC1 between 1 and 3 days, Npc1-/- mice (n =9) treated with 1.3 × 1012 GC of AAV9-CamKII-NPC1 between 20 and 25 days of life, Npc1-/- mice (n =6) treated with 1.2 × 1012 GC of AAV9-CamKII-GFP between 20 and 25 days of life and untreated Npc1-/- mice (n =16). (B) Survival data depicted as a vertical scatter plot to show survival distribution. (C) Week at which Npc1-/- mice reached peak weight. (D) Percentage weight change between weeks 6 and 9. **P <0.01, ***P <0.001, Log-ranked (Mantel Cox) test or t-test two-tailed.